A Patient‐Centric, Digital Multimodal Post‐Market Approval Continuous Monitoring of Drug Safety & Efficacy Platform for Blarcamesine

20250 citationsJournal Articlehybrid Open Access

Authors

Audrey Gabelle

Marwan N. Sabbagh · Barrow Neurological Institute

Timo Grimmer · Technical University of Munich

Luca Villa · Erdyn (France)

Elizabeth Gordon · Erdyn (France)

Mathilde Borrot · Erdyn (France)

Ayoub Gueddou · Erdyn (France)

Abstract

This post-market approval continuous monitoring platform may benefit all stakeholders, including patients, clinicians, regulators, service providers and payors. This modularly digital platform can be customized to fit also other post-market approval monitoring.

Topics & Keywords

Dementia and Cognitive Impairment Research Functional Brain Connectivity Studies Epilepsy research and treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Alzheimer s & Dementia

Volume 21, Issue S5, pp. e106459-e106459

DOI: 10.1002/alz70859_106459

Field-Weighted Citation Impact: 0.00

Command Palette